Relyvrio

(phenylbutyrate / taurursodiol)
relyvrio 3 GM / 1 GM Powder for Oral Suspension
NO BLACK BOX WARNING

Dosage & administration

drug label

Relyvrio prescribing information

prior authorization

Relyvrio prior authorization resources

PDF
Complete Letter of Medical Necessity

PDF
Coverage Authorization Appeals
Learn More

Benefits investigation

PDF
Relyvrio Enrollment Form
Learn More

financial assistance

Relyvrio financial assistance options

Co-pay savings program

commercial only

PDF
Relyvrio Enrollment Form

OTHER
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only

PDF
Relyvrio Enrollment Form

OTHER
Interim Rx (Bridge) Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

PDF
Relyvrio Enrollment Form
Learn More

patient education

Relyvrio patient education

Getting started on Relyvrio

BRAND PAGE
Instructions For Use: ALS
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

BRAND PAGE
About Relyvrio
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
View How to Take Relyvrio
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
What To Expect With Relyvrio
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
ACT Support Program Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Relyvrio FAQs

How is the dosage of Relyvrio?Relyvrio is available in 1 dosages, including 3,000-1,000 mg Pwdr
What does Relyvrio treat?Relyvrio treats Amyotrophic Lateral Sclerosis, Sickle Cell Anemia, Cystic Fibrosis, Myeloproliferative Disorders and beta-Thalassemia
How Is Relyvrio Administered?Relyvrio is administered as a Oral Suspension Powder
FAQ Data Source